| Cat. No. |
Product Name |
Information |
| PC-20127 |
LEI-106
DAGL-α/ABHD6 inhibitor
|
LEI-106 (LEI 106) is a potent, dual DAGL-α/ABHD6 inhibitor with Ki values of 0.7/0.8 uM, respectively. |
| PC-20126 |
RHC-80267
DAGL inhibitor
|
RHC-80267 (U 57908) is a small molecule inhibitor of diacylglycerol lipase (DAGL) with IC50 values of 1.1 and 4 μM in rat cardiac myocytes and canine platelets respectively. |
| PC-20125 |
Orlistat
Lipase inhibitor
|
Orlistat ((–)-Tetrahydrolipstatin, Ro-18-0647) is a small molecule inhibitor of pancreatic and gastric lipase, inhibits DAGLα, DAGLβ, ABHD12, ABHD16A, and platelet-activating factor acetylhydrolase (PAF-AH) with IC50 of 0.06, 0.1, 0.08, 0.03, and 0.05 µM, respectively. |
| PC-62857 |
LEI-105
DAGL inhibitor
|
LEI-105 (LEI 105) is a potent, highly selective, and reversible dual DAGL-α/DAGL-β inhibitor with pIC50 of 7.5/7.4 respectively. |
| PC-61839 |
KT-172
DAGLβ inhibitor
|
KT-172 is a potent, selective inhibitor of DAGLβ with IC50 of 60 nM. |
| PC-61838 |
KT-109
DAGLβ inhibitor
|
KT-109 (KT109) is a potent, selective inhibitor of DAGLβ with IC50 of 42 nM, displays about 60-fold selectivity over DAGLα. |
| PC-61837 |
DAGL inhibitor DO34
DAGLα/β inhibitor
|
DAGL inhibitor DO34 is a highly potent dual DAGLα/β inhibitor with IC50 of 6 nM 3-8 nM, respectively. |
| PC-61836 |
DH-376
DAGLα/β inhibitor
|
DH-376 is a highly potent dual DAGLα/β inhibitor with IC50 of 6 nM and 3-8 nM, respectively. |
